HIGHLIGHTS
- who: Juanyan Liao from the Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Sichuan, Chengdu, China have published the Article: Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma, in the Journal: (JOURNAL)
- what: Our report firstly displayed ceritinib-associated granulomatous pneumonia in ALK-NSCLC confirmed by pathology.
SUMMARY
Anaplastic lymphoma kinase gene rearrangement occurs in 2-7% of non-small cell lung cancer (NSCLC) patients, especially in young, female, adenocarcinoma, non-smoking patients. The authors reported that two patients with advanced ALK-rearranged pulmonary adenocarcinoma . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.